The stock's rise snapped a three-day losing streak.

The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as ...

Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, March 11th. William ...

Shares of Henry Schein Inc. HSIC slipped 4.09% to $69.94 Wednesday, on what proved to be an all-around mixed trading session ...

Henry Schein is supporting the Special Olympics Healthy Athletes screenings at the Special Olympics World Winter Games March 8-15, 2025, in Turin, Italy, by donating a range of oral ...

Utah Gov. Spencer Cox (Rep.) plans to sign a bill from his state's House and Senate that would ban adding fluoride to public ...

BofA notes that Utah’s House and Senate passed a bill that would ban the fluoridation of water and that news sources indicate that Utah’s ...

Highlights,Charles Schwab Investment Management increased its holdings in Henry Schein, reaching close to 1% ownership.,Institutional investors actively adjusted their positions, reflecting evolving ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that ...

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

Learn more about whether Henry Schein, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...